Probiotic Supplement as Treatment for Students With ADHD
NCT ID: NCT02908802
Last Updated: 2018-09-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
45 participants
INTERVENTIONAL
2016-11-30
2019-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* Symptom severity and improvement will be measured using ADHA Rating scale IV (ADHD RS)
* Demographic Questionnaire - composed by the researchers
* Family Eating Habits Questionnaire (FEAHQ-33)
* Food Frequency Questionnaire (FFQ)
* Test MOXO
The subjects will take the study product for six months.
After six months the subject will fill once again all the questionnaires.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effectiveness of Probiotic Supplement In Improving Attention Deficit Hyperactivity Disorder Symptoms
NCT04333394
Multi-strain Probiotics for ADHD
NCT06226584
Effect of Nutritional Formula Supplementation on Growth of Prepubertal Children Treated With Stimulants Medications for Attention Deficit Hyperactivity Disorder (ADHD)
NCT04962334
The Safety and Efficacy of a Compound Natural Health Product in Children With Attention Deficit Hyperactivity Disorder (ADHD)
NCT01022229
A Study of PDC-1421 Treatment in Adult Patients With Attention-Deficit Hyperactivity Disorder (ADHD)
NCT02699086
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Subjects will answer the following questionnaire and tests:
* Symptom severity and improvement will be measured using ADHA Rating scale IV (ADHD RS)
* Demographic Questionnaire - composed by the researchers
* Family Eating Habits Questionnaire (FEAHQ-33)
* Food Frequency Questionnaire (FFQ)
* Test MOXO
The subjects will take the study product for six months.
After six months the subject will fill once again all the questionnaires.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Probiotic
Probiotic capsules: two capsules twice a day
Probiotic
Probiotic
Placebo
Probiotic capsules without the active ingredient: two capsules twice a day
Placebo
Probiotics capsules without the active ingredient
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Probiotic
Probiotic
Placebo
Probiotics capsules without the active ingredient
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Students who are not treated by medication or alternative treatment,
* Students who are not due to complete their education at Tel Hai College during the study period,
* Students who have signed on an informed consent form,
* No dairy intolerance (student can consume milk without any adverse effects),
* No soy allergy,
* Not currently taking any antibiotics or probiotics,
* Not pregnant or planning to become pregnant during the study period,
* Not been diagnosed with any of the following:
* Cancer
* HIV/AIDS
* Crohn's disease
* Ulcerative colitis
* Immune compromised illness
* Other serious illness
Exclusion Criteria
* Students who have not been assessed by MATAL and a psychiatrist,
* Students who take antibiotics.
19 Years
30 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tel Hai College
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
40-16
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.